Income Statement Rapid Dose Therapeutics Corp. OTC Markets

Stocks

RDTCF

CA75339A1012

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 09:30:00 2026-09-03 EDT			5-day change	1st Jan Change
0.0850 ^USD	0.00%		0.00%	-5.56%

07-30	Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 31, 2026	CI
07-29	Rapid Dose Therapeutics Corp And Bodhi Health Inc Expand Distribution And Sales Of CurcuWIN QuickStrip Curcumin Across Canada	CI

84db538a3b7bc1378b8e37dc5909c326.n0vITpTRBdShA2Ljm6X3ntbizLTaM6Pn7NkUMomXn1Y.6X-dfaKSM43yWha6-pad5uWUrf6zVu-KlKhfBePi6TeqAIMq5eZTrtltCQ

Published financial data: RAPID DOSE THERAPEUTICS CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: February	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Revenues	1.75M	718K	1.02M	2.09M	2.77M
Total Revenues	1.75M	718K	1.02M	2.09M	2.77M
Cost of Goods Sold, Total	544K	346K	457K	905K	1.41M
Gross Profit	1.21M	372K	563K	1.18M	1.36M
Selling General & Admin Expenses, Total	2.85M	2.47M	2.44M	3.55M	2.67M
Provision for Bad Debts	-	15.62K	-5.97K	-	-
Stock-Based Compensation (IS)	1.53M	707K	162K	1.42M	320K
R&D Expenses	359K	92.88K	428K	148K	33.19K
Depreciation & Amortization - (IS)	766K	627K	620K	241K	513K
Other Operating Expenses, Total	5.51M	3.92M	3.64M	5.35M	3.53M
Operating Income	-4.3M	-3.54M	-3.08M	-4.17M	-2.17M
Interest Expense, Total	-133K	-265K	-661K	-1.23M	-1.22M
Interest And Investment Income	363	-	-	-	-
Net Interest Expenses	-133K	-265K	-661K	-1.23M	-1.22M
Currency Exchange Gains (Loss)	23.92K	-1.61K	-8.9K	-	-
Other Non Operating Income (Expenses)	8.46K	-	-	-	-
EBT, Excl. Unusual Items	-4.4M	-3.81M	-3.75M	-5.4M	-3.39M
Impairment of Goodwill	-4.08M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	-	-	-559K	-	-
EBT, Incl. Unusual Items	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Earnings From Continuing Operations	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Net Income to Company	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Net Income - (IS)	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Net Income to Common Incl Extra Items	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Net Income to Common Excl. Extra Items	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Per Share Items
Net EPS - Basic	-0.08	-0.04	-0.04	-0.04	-0.03
Basic EPS - Continuing Operations	-0.08	-0.04	-0.04	-0.04	-0.03
Basic Weighted Average Shares Outstanding	100M	103M	105M	125M	133M
Net EPS - Diluted	-0.08	-0.04	-0.04	-0.04	-0.03
Diluted EPS - Continuing Operations	-0.08	-0.04	-0.04	-0.04	-0.03
Diluted Weighted Average Shares Outstanding	100M	103M	105M	125M	133M
Normalized Basic EPS	-0.03	-0.02	-0.02	-0.03	-0.02
Normalized Diluted EPS	-0.03	-0.02	-0.02	-0.03	-0.02
Supplemental Items
EBITDA	-3.82M	-3.2M	-2.75M	-3.95M	-2M
EBITA	-4.3M	-3.54M	-3.08M	-4.17M	-2.17M
EBIT	-4.3M	-3.54M	-3.08M	-4.17M	-2.17M
EBITDAR	-	-	-	-	-
Normalized Net Income	-2.75M	-2.38M	-2.34M	-3.38M	-2.12M
Interest on Long-Term Debt	66.41K	42.7K	17.03K	195	210K
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	160K	228K	242K	721K	353K
General and Administrative Expenses	1.1M	854K	1M	1.43M	829K
Research And Development Expense From Footnotes	359K	92.88K	428K	148K	33.19K
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	1.7M	707K	162K	1.57M	370K
Total Stock-Based Compensation	1.7M	707K	162K	1.57M	370K

Fiscal Period: February	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Assets
Cash And Equivalents	34.44K	27.59K	161K	20.72K	11.55K
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	34.44K	27.59K	161K	20.72K	11.55K
Accounts Receivable, Total	71.9K	60.27K	33.03K	143K	98.96K
Other Receivables	111K	85.76K	186K	160K	69.31K
Total Receivables	183K	146K	219K	303K	168K
Inventory	277K	157K	170K	256K	160K
Prepaid Expenses	120K	60.13K	98.83K	55.19K	24.15K
Other Current Assets, Total	-	29.34K	29.34K	29.34K	-
Total Current Assets	614K	420K	679K	664K	364K
Gross Property Plant And Equipment	4.54M	4.54M	4.54M	4.54M	5.47M
Accumulated Depreciation	-2.08M	-2.71M	-3.33M	-3.57M	-2.62M
Net Property Plant And Equipment	2.45M	1.83M	1.21M	971K	2.85M
Other Long-Term Assets, Total	-	-	-	-	64.8K
Total Assets	3.07M	2.25M	1.89M	1.63M	3.28M
Liabilities
Accounts Payable, Total	1.36M	2.78M	1.12M	1.94M	2.15M
Accrued Expenses, Total	-	-	1.47M	2.29M	2.53M
Short-term Borrowings	759K	1.57M	206K	2.61M	3.07M
Current Portion of Long-Term Debt	-	-	93.36K	-	-
Current Portion of Leases	309K	335K	29.14K	-	234K
Unearned Revenue Current, Total	23.34K	13.3K	-	-	-
Other Current Liabilities	-	-	-	-	459K
Total Current Liabilities	2.45M	4.7M	2.92M	6.84M	8.44M
Long-Term Debt	-	187K	2.12M	-	-
Long-Term Leases	364K	29.14K	-	-	2.01M
Total Liabilities	2.82M	4.92M	5.04M	6.84M	10.46M
Common Stock, Total	25M	25.13M	26.61M	28.26M	29.28M
Additional Paid In Capital	4.15M	4.85M	5.24M	6.65M	7M
Retained Earnings	-31.16M	-34.97M	-39.26M	-44.6M	-47.99M
Comprehensive Income and Other	2.26M	2.32M	4.24M	4.49M	4.53M
Total Common Equity	252K	-2.67M	-3.16M	-5.21M	-7.18M
Total Equity	252K	-2.67M	-3.16M	-5.21M	-7.18M
Total Liabilities And Equity	3.07M	2.25M	1.89M	1.63M	3.28M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	103M	104M	122M	130M	135M
ECS Total Common Shares Outstanding	103M	104M	118M	130M	135M
Book Value / Share	0	-0.03	-0.03	-0.04	-0.05
Tangible Book Value	252K	-2.67M	-3.16M	-5.21M	-7.18M
Tangible Book Value Per Share	0	-0.03	-0.03	-0.04	-0.05
Total Debt	1.43M	2.12M	2.45M	2.61M	5.32M
Net Debt	1.4M	2.1M	2.29M	2.59M	5.31M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	103K	60.83K	56.41K	45.33K	37.48K
Inventories - Finished Goods, Total	207K	30.63K	8.07K	115K	46.97K
Inventories - Others	79.27K	66.59K	67.99K	87.13K	75.7K
Machinery, Total	2.39M	2.39M	2.39M	2.4M	2.4M
Accumulated Allowance for Doubtful Accounts (Supple)	-	15.62K	-	-	-

Fiscal Period: February	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Net Income	-8.49M	-3.81M	-4.31M	-5.4M	-3.39M
Depreciation & Amortization - CF	766K	627K	620K	241K	513K
Depreciation & Amortization, Total	766K	627K	620K	241K	513K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	4.08M	-	-	-	-
Stock-Based Compensation (CF)	1.7M	707K	162K	1.57M	370K
Provision and Write-off of Bad Debts	-	15.62K	-5.97K	-	-
Other Operating Activities, Total	149K	134K	746K	934K	1.07M
Change In Accounts Receivable	203K	21.14K	-67.32K	-83.3K	134K
Change In Inventories	-39.65K	78.58K	12.58K	-115K	86.86K
Change In Accounts Payable	-470K	1.31M	621K	1.64M	935K
Change in Unearned Revenues	-879K	-10.04K	-13.3K	-	-
Change in Other Net Operating Assets	-21.58K	58.82K	-64.54K	72.7K	4.44K
Cash from Operations	-3M	-864K	-2.29M	-1.15M	-270K
Capital Expenditure	-40.36K	-	-	-5.74K	-899
Sale of Property, Plant, and Equipment	1.2K	-	-	-	-
Cash Acquisitions	1.89M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	1.85M	-	-	-5.74K	-899
Short Term Debt Issued, Total	130K	813K	433K	-	190K
Long-Term Debt Issued, Total	-	201K	1.83M	-	459K
Total Debt Issued	130K	1.01M	2.26M	-	649K
Short Term Debt Repaid, Total	-	-	-700K	-250K	-240K
Long-Term Debt Repaid, Total	-286K	-309K	-335K	-129K	-147K
Total Debt Repaid	-286K	-309K	-1.04M	-379K	-387K
Issuance of Common Stock	1.28M	152K	1.3M	1.39M	-
Other Financing Activities, Total	-	-	-94.86K	-	-
Cash from Financing	1.13M	857K	2.43M	1.01M	262K
Foreign Exchange Rate Adjustments	-18.64K	534	-	-	-
Net Change in Cash	-35.82K	-6.86K	133K	-140K	-9.16K
Supplemental Items
Cash Interest Paid	66.41K	82.93K	173K	-	-
Levered Free Cash Flow	-1.55M	551K	-1.88M	-60.23K	-39.17K
Unlevered Free Cash Flow	-1.47M	716K	-1.47M	710K	722K
Change In Net Working Capital	1.2M	-1.6M	330K	-1.52M	-1.2M
Net Debt Issued / Repaid	-156K	705K	1.22M	-379K	262K

Fiscal Period: February	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)
Profitability
Return on Assets	-77.93	-83.34	-93.1	-148.14	-55.19
Return on Total Capital	-193.25	-389.55	307.43	158.02	60.99
Return On Equity %	2.03K	315.07	147.78	129.23	54.76
Return on Common Equity	2.03K	315.07	147.78	129.23	54.76
Margin Analysis
Gross Profit Margin %	68.97	51.85	55.21	56.59	49.15
SG&A Margin	162.79	344.33	238.76	170.09	96.18
EBITDA Margin %	-218.31	-446.17	-269.06	-189.66	-72.11
EBITA Margin %	-245.55	-493.36	-301.57	-200.07	-78.29
EBIT Margin %	-245.55	-493.36	-301.57	-200.07	-78.29
Income From Continuing Operations Margin %	-484.47	-530.42	-422.03	-259.18	-122.22
Net Income Margin %	-484.47	-530.42	-422.03	-259.18	-122.22
Net Avail. For Common Margin %	-484.47	-530.42	-422.03	-259.18	-122.22
Normalized Net Income Margin	-157.06	-331.52	-229.54	-161.98	-76.39
Levered Free Cash Flow Margin	-88.59	76.69	-184.6	-2.89	-1.41
Unlevered Free Cash Flow Margin	-83.83	99.72	-144.09	34.05	26.05
Asset Turnover
Asset Turnover	0.51	0.27	0.49	1.18	1.13
Fixed Assets Turnover	0.64	0.34	0.67	1.92	1.45
Receivables Turnover (Average Receivables)	22.35	10.87	21.87	23.69	22.92
Inventory Turnover (Average Inventory)	1.68	1.59	2.79	4.25	6.78
Short Term Liquidity
Current Ratio	0.25	0.09	0.23	0.1	0.04
Quick Ratio	0.09	0.04	0.13	0.05	0.02
Operating Cash Flow to Current Liabilities	-1.22	-0.18	-0.79	-0.17	-0.03
Days Sales Outstanding (Average Receivables)	16.33	33.58	16.73	15.41	15.92
Days Outstanding Inventory (Average Inventory)	216.86	229.14	131.14	85.94	53.84
Average Days Payable Outstanding	1.29K	3.35K	1.52K	563.59	567.56
Cash Conversion Cycle (Average Days)	-1.06K	-3.08K	-1.37K	-462.24	-497.8
Long Term Solvency
Total Debt/Equity	569.46	-79.52	-77.7	-50.13	-74.16
Total Debt / Total Capital	85.06	-388.17	-348.39	-100.54	-286.99
LT Debt/Equity	144.77	-8.09	-67.29	-	-28.06
Long-Term Debt / Total Capital	21.62	-39.51	-301.71	-	-108.58
Total Liabilities / Total Assets	91.8	218.84	267.52	418.39	318.59
EBIT / Interest Expense	-32.23	-13.39	-4.65	-3.39	-1.78
EBITDA / Interest Expense	-26.49	-11.02	-3.71	-3.19	-1.36
(EBITDA - Capex) / Interest Expense	-26.79	-11.02	-3.71	-3.19	-1.36
Total Debt / EBITDA	-0.41	-0.73	-1	-0.66	-3.21
Net Debt / EBITDA	-0.4	-0.72	-0.93	-0.66	-3.2
Total Debt / (EBITDA - Capex)	-0.4	-0.73	-1	-0.66	-3.21
Net Debt / (EBITDA - Capex)	-0.39	-0.72	-0.93	-0.66	-3.2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	131.98	-59	42.06	104.34	33
Gross Profit, 1 Yr. Growth %	91.85	-72.31	57.91	109.45	15.51
EBITDA, 1 Yr. Growth %	206.53	-16.2	-14.33	43.58	-49.43
EBITA, 1 Yr. Growth %	163.17	-17.62	-13.16	35.18	-47.96
EBIT, 1 Yr. Growth %	163.17	-17.62	-13.16	35.18	-47.96
Earnings From Cont. Operations, 1 Yr. Growth %	370.15	-55.11	13.03	25.49	-37.28
Net Income, 1 Yr. Growth %	370.15	-55.11	13.03	25.49	-37.28
Normalized Net Income, 1 Yr. Growth %	143.88	-13.46	-1.64	44.2	-37.28
Diluted EPS Before Extra, 1 Yr. Growth %	264.94	-56.5	11.36	5.74	-41.23
Accounts Receivable, 1 Yr. Growth %	-15.32	-16.17	-45.2	333	-30.81
Inventory, 1 Yr. Growth %	-24.82	-43.31	8.44	50.17	-37.41
Net Property, Plant and Equip., 1 Yr. Growth %	-19.12	-25.57	-33.96	-19.48	193.82
Total Assets, 1 Yr. Growth %	-19.93	-26.77	-16.09	-13.27	100.77
Tangible Book Value, 1 Yr. Growth %	-123.08	-1.16K	18.27	64.84	37.84
Common Equity, 1 Yr. Growth %	-123.08	-1.16K	18.27	64.84	37.84
Cash From Operations, 1 Yr. Growth %	84.74	-71.2	165.65	-50.03	-76.42
Capital Expenditures, 1 Yr. Growth %	342.31	-	-	-	-84.34
Levered Free Cash Flow, 1 Yr. Growth %	39.32	-135.49	-441.94	-96.81	-34.97
Unlevered Free Cash Flow, 1 Yr. Growth %	43.3	-148.77	-305.26	-148.11	1.74
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	315.46	-2.47	-23.68	70.38	64.86
Gross Profit, 2 Yr. CAGR %	468.89	-23.11	-35.27	81.86	55.54
EBITDA, 2 Yr. CAGR %	-27.67	60.27	-15.27	11.09	-14.79
EBITA, 2 Yr. CAGR %	-24.29	47.24	-15.42	8.5	-16.12
EBIT, 2 Yr. CAGR %	-24.29	47.24	-15.42	8.5	-16.12
Earnings From Cont. Operations, 2 Yr. CAGR %	3.23	45.28	-28.77	19.1	-11.28
Net Income, 2 Yr. CAGR %	3.23	45.28	-28.77	19.1	-11.28
Normalized Net Income, 2 Yr. CAGR %	-23.28	45.28	-7.74	19.1	-4.9
Diluted EPS Before Extra, 2 Yr. CAGR %	-10.05	26	-30.4	8.52	-21.17
Accounts Receivable, 2 Yr. CAGR %	40.13	-15.75	-32.22	54.04	73.09
Inventory, 2 Yr. CAGR %	14.78	-34.72	-21.6	27.61	-3.05
Net Property, Plant and Equip., 2 Yr. CAGR %	-20.43	-22.41	-29.89	-27.08	53.81
Total Assets, 2 Yr. CAGR %	-15.43	-23.43	-21.62	-14.7	31.96
Tangible Book Value, 2 Yr. CAGR %	30.47	56.53	254.31	39.63	50.74
Common Equity, 2 Yr. CAGR %	30.47	56.53	254.31	39.63	50.74
Cash From Operations, 2 Yr. CAGR %	-0.55	-27.06	-12.53	15.21	-65.68
Capital Expenditures, 2 Yr. CAGR %	-81.84	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	0.57	-29.68	10.17	-66.93	-85.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.07	-16.4	0.06	-0.44	-30.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	91.99	10.55	5.98	56.88
Gross Profit, 3 Yr. CAGR %	-	115.26	-3.65	-4.26	56.33
EBITDA, 3 Yr. CAGR %	7.03	-24.03	30.07	1.12	-14.55
EBITA, 3 Yr. CAGR %	9.51	-22.13	23.48	-1.02	-15.07
EBIT, 3 Yr. CAGR %	9.51	-22.13	23.48	-1.02	-15.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-9.36	-21.79	33.62	-13.97	-3.82
Net Income, 3 Yr. CAGR %	-9.36	-21.79	33.62	-13.97	-3.82
Normalized Net Income, 3 Yr. CAGR %	10.36	-20.14	27.57	7.07	-3.82
Diluted EPS Before Extra, 3 Yr. CAGR %	-22.46	-29.4	20.92	-19.99	-11.55
Accounts Receivable, 3 Yr. CAGR %	-	18.07	-27	25.76	17.97
Inventory, 3 Yr. CAGR %	25.91	-9.27	-22.69	-2.63	0.64
Net Property, Plant and Equip., 3 Yr. CAGR %	13.38	-22.18	-26.47	-26.58	16.04
Total Assets, 3 Yr. CAGR %	-19.05	-19.39	-21.06	-18.93	13.47
Tangible Book Value, 3 Yr. CAGR %	-59.64	162.4	42.57	174.54	39.03
Common Equity, 3 Yr. CAGR %	-59.64	162.4	42.57	174.54	39.03
Cash From Operations, 3 Yr. CAGR %	12.05	-34.2	12.23	-27.42	-32.1
Capital Expenditures, 3 Yr. CAGR %	-71.07	-	-	-47.8	-
Levered Free Cash Flow, 3 Yr. CAGR %	-34.58	-28.93	19.14	-66.14	-58.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	-35.77	-21.25	12.78	-21.51	0.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	83.04	29.71
Gross Profit, 5 Yr. CAGR %	-	-	-	99.5	16.7
EBITDA, 5 Yr. CAGR %	-	12.22	-2.52	-11.56	9.9
EBITA, 5 Yr. CAGR %	-	14.48	-1.24	-11.08	5.84
EBIT, 5 Yr. CAGR %	-	14.48	-1.24	-11.08	5.84
Earnings From Cont. Operations, 5 Yr. CAGR %	-	16.15	-17.69	-7.46	13.43
Net Income, 5 Yr. CAGR %	-	16.15	-17.69	-7.46	13.43
Normalized Net Income, 5 Yr. CAGR %	-	16.15	2.73	-6.3	13.43
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-6.96	-25.74	-16.15	1.9
Accounts Receivable, 5 Yr. CAGR %	-	-	-	31.32	3.11
Inventory, 5 Yr. CAGR %	-	-	4.18	3.99	-15.36
Net Property, Plant and Equip., 5 Yr. CAGR %	-	60.28	-6.45	-24.18	-1.22
Total Assets, 5 Yr. CAGR %	-	25.26	-20.08	-17.55	-3.05
Tangible Book Value, 5 Yr. CAGR %	-	35.31	-3.77	103.88	45.78
Common Equity, 5 Yr. CAGR %	-	35.31	-3.77	103.88	45.78
Cash From Operations, 5 Yr. CAGR %	-	1.42	1.48	-17.68	-30.13
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-65.78	-37.09
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-19.42	-47.67	-48.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-23.31	-13.5	-6.76